HIGHLIGHTS
- who: Yu-Mei Ning from the Department of Gastroenterology, Zhongnan Hospital of Wuhan University, No, Donghu Road, Wuhan, Hubei Province, China have published the research: NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma, in the Journal: (JOURNAL)
- what: In line with these results, enrichment analyses in this study showed the genes most related to NAPSB were enriched in immune cell receptor signaling pathway and inflammatory response in the study . Despite these findings, there is existing the limitation that the study was primarily carried out . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.